Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 1999, p. 393-396, Vol. 43, No. 2
Sera and Vaccines Central Research
Laboratory,
Received 18 May 1998/Returned for modification 7 September
1998/Accepted 5 November 1998
Twelve SHV-type extended-spectrum
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Diversification of Escherichia coli
Expressing an SHV-Type Extended-Spectrum
-Lactamase (ESBL)
during a Hospital Outbreak: Emergence of an ESBL-Hyperproducing Strain
Resistant to Expanded-Spectrum Cephalosporins
ucha,1
noc,
-lactamase (ESBL)-producing
Escherichia coli lac mutant isolates were recovered in
October 1997 from 11 patients of the neonatal ward in a Warsaw
hospital. The outbreak was clonal; however, some of the isolates
expressed a much higher level of resistance to several
-lactam
antibiotics, including expanded-spectrum cephalosporins. This phenotype
has been attributed to
-lactamase hyperproduction correlating with the multiplication of ESBL gene copies, as was demonstrated for representative isolates.
*
Corresponding author. Mailing address: Sera and
Vaccines Central Research Laboratory, ul. Che
mska 30/34, 00-725 Warsaw, Poland. Phone: (48) 22-651 46 70. Fax: (48) 22-41 29 49. E-mail: marekg{at}ibbrain.ibb.waw.pl.
Antimicrobial Agents and Chemotherapy, February 1999, p. 393-396, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»